Skip to content

Opko Health OPK Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
Precigen logo
PrecigenPGEN
Immunome logo
ImmunomeIMNM
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B+10.0%
P/S1.9×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's software and technology licenses, net?
Opko Health (OPK) reported software and technology licenses, net of $18.9M in Q1 2026.
How has Opko Health's software and technology licenses, net changed year-over-year?
Opko Health's software and technology licenses, net increased by 0.7% year-over-year, from $18.77M to $18.9M.
What is the long-term trend for Opko Health's software and technology licenses, net?
Over 5 years (2020 to 2025), Opko Health's software and technology licenses, net has grown at a 14.1% compound annual growth rate (CAGR), from $10.06M to $19.47M.